Tennessee voters pick candidates for governor and congressional seats in midterm primary
Andy Ogles of Tennessee has lost his Republican primary, NBC News projects, falling to a former state official in a primary ...
FDA approves first-ever mRNA flu vaccine for millions of older Americans
A new mRNA flu vaccine showed a 27% reduction in flu cases in a clinical trial, but its path to FDA approval faced an early ...
FDA approves Moderna’s mRNA-based flu vaccine
WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made ...
FDA approves first mRNA-based flu vaccine
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...
FDA approves 1st flu shot using same technology as COVID vaccines
Previously, the COVID-19 immunizations made by Pfizer and Moderna were the only mRNA vaccines on the market.
A new type of flu shot is coming after FDA approves mRNA-based vaccine
The agency's former top vaccine regulator declined to review the Moderna shot, and it's now likely to face pushback from ...
Reuters
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug
July 13 (Reuters) - The U.S. FDA on Monday approved an at-home starting dose of Eisai's (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Alzheimer's drug, allowing some patients to begin ...
WebMD
FDA Approves At-Home Starting Dose for Alzheimer's Drug Leqembi
What Is Leqembi, and Why Does It Matter? Leqembi (lecanemab) is a prescription medicine for Alzheimer's disease. This disease is a brain disorder that slowly destroys memory and thinking skills. Over ...
MedPage Today
FDA Approves At-Home Starter Dose of Alzheimer's Drug
The FDA approved a new starting dosage regimen for the subcutaneous formulation of lecanemab (Leqembi Iqlik) to treat adults with Alzheimer's disease, the agency said Monday. Lecanemab is an ...
The American Journal of Managed Care
FDA Approved At-Home SC Lecanemab Initiation Dose for Early Alzheimer Disease
Once-weekly 500 mg subcutaneous initiation is delivered by autoinjector as two 250 mg injections, allowing self- or caregiver administration at home rather than clinic-based IV starts. FDA acceptance ...
Becker's Hospital Review
FDA approves 1st on-body cancer drug
The FDA has approved Sanofi’s subcutaneous Sarclisa Escena in combination with standard-of-care regimens for patients with multiple myeloma across all existing indications of the intravenous ...
Reuters
US FDA approves Celcuity's breast cancer drug
July 14 (Reuters) - The U.S. FDA has approved Celcuity's (CELC.O), opens new tab drug for an advanced form of breast cancer, the regulator said on Tuesday, making it the ‌company's first product to ...